FIIs reduce stake in Wockhardt during March quarter

18 Apr 2014 Evaluate

Foreign institutional investors (FIIs) have reduced their shareholding in Wockhardt to 3.71% at the end of March 2014 quarter from 4.86% as on December 31, 2013. On the other hand, domestic institutional investors’ (DIIs) shareholding went up to 4.12% at the end of March 2014 quarter from 3.39% as on December 31, 2013. Meanwhile, promoter and promoter group shareholding was unchanged at 74.70% at the end of March 2014 quarter.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

585.00 11.40 (1.99%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.